Sunday, 2 June 2013

The momentum strategy (May 2013)

 For MAY 2013, the updated result is as follows:

Date   Top1   Top2   Top3   Total Equity   Monthly return   Total return
1/31/2012   CIE   REGN   MNST   19,330.50        
2/29/2012   CIE   REGN   SOA   24,138.21   23.83%   20.81%
3/31/2012   CIE   REGN   AMLN   25,342.71   2.92%   26.84%
4/30/2012   CIE   REGN   AMLN   25948.91   2.44%   29.87%
5/31/2012   REGN   AMLN   MNST   24754.27   -5.24%   23.90%
6/30/2012   REGN   AMLN   CHSI   23520.91        
07/02/2012   REGN   EXPE   CHSI   24421.45   -1.34%   22.23%
7/27/2012   REGN   EXPE   CTRX   24299.32386   -1.84%   21.62%
7/31/2012   REGN   EXPE   ALXN   26203.11   11.40%   31.15%
09/05/2012   REGN   EXPE   EQIX   26443.48   0.92%   32.35%
9/28/2012   REGN   EXPE   EQIX   27888.21   5.46%   39.58%
10/31/2012   REGN   EXPE   WLK   26507.62798   -4.95%   32.67%
11/30/2012   REGN   EXPE   VAC   29135.33875   9.91%   45.82%
12/31/2012   REGN   SSYS   WLK   28690.95875   -1.53%   43.60%
1/31/2013   GMCR   THC   NFLX   30097.76   4.90%   50.64%
2/28/2013   LNKD   THC   NFLX   32002.2662   6.33%   60.17%
3/28/2013   STRZA   THC   NFLX   34641.1162   8.25%   73.38%
4/30/2013   STRZA   VRTX   NFLX   36001.24   3.93%   80.19%
5/31/2013   GMCR   TSLA   NFLX   36675.11   1.87%   83.56%

The heart breaking story is TSLA ranked lower than VRTX last month and was thus not purchased. The stock shot up nearly150% during May 2013. Can you hear the sound of my heart breaking? :-(

Disclaimer
Please note that the information in the blog are provided for you by way of information only.  All the information, report and analysis were and should be taken as having been prepared for the purpose of general circulation and that none were made with regard to any specific investment objectives, financial situation and particular needs of any particular person who may receive the information, report or analysis (including yourself). Any recommendation or advice that may be expressed in or inferred from such information, reports or analysis therefore does not take into account and may not be suitable for your investment objectives, financial situation and particular needs

No comments:

Post a Comment